Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Head of global research and development at Life Technologies
Founder, Gilt Groupe
President and CEO of the Central Indiana Corporate Partnership
The WBBA is hosting a forum on translational medicine on Oct. 12, honing in on the process of turning biological discoveries into drugs and/or medical devices that can help patients better, faster, and cheaper. Speakers include Tom Clement, the CEO of Aqueduct; Tom Fritz, the CEO of Inland Northwest Health Services; Mike Gallatin, the former president of Calistoga Pharmaceuticals; Jeffrey Herz, the founder and president of Algomedix; and Gary Jones, the chief medical officer of C3 Research Associates. For more information on how to register, click here.